Drugs / Nonoxynol-9
Nonoxynol-9
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | DELFEN | — | 1963-12-10 | fda.gov ↗ |
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02545452 | Sep 2015 → Mar 2016 | endometriosis | Bayer | Completed | No outcome recorded |
| Phase 1 | NCT00000929 | ? → Jul 1999 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00578877 | Jan 2008 → Oct 2009 | — | CONRAD | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00000926 | ? → Feb 2001 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT00389311 Comparator | Apr 2007 → Feb 2008 | HIV infectious disease | Johns Hopkins University | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT01232803 Comparator | Oct 2010 → Jul 2011 | — | CONRAD | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01593124 Comparator | May 2012 → Apr 2013 | infective vaginitis | CONRAD | Completed | No outcome recorded |
| Phase 2 | NCT00692952 Comparator | Mar 2004 → Nov 2005 | — | Shanghai Institute of Planned Parenthood Research | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01306331 Comparator | Apr 2011 → Jun 2014 | — | Evofem Inc. | Completed | No outcome recorded |
Evidence & citations 26 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nonoxynol-9 | “Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.” NCT01306331 ↗8“75 mg Nonoxynol-9 per day for 3 consecutive days” NCT02545452 ↗ “a 2% nonoxynol-9 gel” PMID 23573238 ↗ Apr 2013 |
| Known as | C-film | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Col-1492 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Delfen | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Double check | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Duragel | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Emko | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Gygel | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Gynol 11 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Igepal co-630 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | LELEMI | “LELEMI® contraceptive gel containing 50mg nonoxynol-9” NCT00692952 ↗ |
| Known as | N-9 | “Ten subjects received 3 one-time interventions: 5 mL of Normosol-R fluid alone (negative control), 5 mL of 2% nonoxynol-9 (N-9) gel, and 5 mL of Normosol-R with coital...” PMID 23325915 ↗ Jan 20132“Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.” NCT01306331 ↗ “A Study of Nonoxynol-9 (N-9) and HIV Infection” NCT00000926 ↗ |
| Known as | Nonoxinol 9 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Nonoxinolum 9 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Nonoxynol-9.5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Nonylphenoxypolyethoxyethanol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Norfox np-9 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | NSC-758941 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Ortho-creme | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Ortho-forms | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Peg-9 nonyl phenyl ether | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Prelude | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Tergitol np-9 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Known as | Today | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗ |
| Modality | Small molecule | — CHEMBL1410 ↗ |
| Route | Other | “Intravaginal application of N-9” NCT00000926 ↗ |